News & Press
Please Read CEO & President Dr. Michael Quirmbach’s Letter to Customers
Dear Valued Customer,
Due to the steep increase in COVID-19 cases taking place globally, I have instructed all CordenPharma employees and manufacturing facilities to cease and cancel all business travel and face-to-face meetings through the end of Q1 2021, and to convert all scheduled customer meetings into video or teleconference calls. Your Key Account Manager will coordinate this for you but feel free to reach out to them with any questions.
In addition, CordenPharma’s Corporate Compliance Team has instructed our global network of facilities to convert all customer-related quality and SHE audits from in-person to virtual meetings through Q1 2021. The local site compliance representatives will reach out to rearrange the audits. Obviously, we will accommodate any regulatory agency audit requests that may arise during this period. We will update you on any changes that take place in the meantime.
Thanks to the consistent efforts and hard work of all CordenPharma employees at the site level, in 2020 we experienced minimal disruptions to our regular operations. We intend to continue this vigilance and success into 2021. Rest assured that all CordenPharma employees, from the Executive Leadership Team and Facility Managing Directors to the Operators and Marketing & Sales Team, are aligned and committed to mitigating any impact on delivering your critical, often lifesaving, medications. We are doing everything possible on our end to support your patients through this crisis.
We appreciate your patience as we react to this global issue, and thank you for your ongoing support in returning to “business as usual” as quickly as possible. Feel free to reach out to your Key Account Managers or fill out this form with any questions or concerns.
I wish you and your families stay safe & healthy, as we continue to work together as a collective community to support business continuity and each other.